Company / PP&E (Net)
Solid Biosciences Inc. PP&E (Net) History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$9.7M
FY2022
5-year range
$6.5M / $11.6M
FY2018-FY2022
Trend
+49.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) returned to growth in FY2022 after 2 years of decline, reaching $10M.
Based on SEC 10-K filings.
$10M in FY2022 with a 3-year CAGR of -6.0%.
Improved from $8M to $10M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -6.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -6.0%, indicating a declining trend.
- In FY2022, pp&e (net) increased 49.4% year-over-year.
- Peak pp&e (net) was recorded in FY2019.
- Lowest pp&e (net) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | $9.7M | +49.4% |
| FY2021 | $6.5M | -20.7% |
| FY2020 | $8.2M | -30.0% |
| FY2019 | $11.6M | +11.7% |
| FY2018 | $10.4M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026